nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparative analysis of the dual EGFR-DNA targeting and growth inhibitory properties of 6-mono-alkylamino- and 6,6-dialkylaminoquinazoline-based type II combi-molecules
|
Schmitt, Julie |
|
|
192 |
C |
p. |
artikel |
2 |
Crystal structure of O-Acetylserine sulfhydralase (OASS) isoform 3 from Entamoeba histolytica: Pharmacophore-based virtual screening and validation of novel inhibitors
|
Dharavath, Sudhaker |
|
|
192 |
C |
p. |
artikel |
3 |
Cyclometalated Ir(III)-8-oxychinolin complexes acting as red-colored probes for specific mitochondrial imaging and anticancer drugs
|
Meng, Ting |
|
|
192 |
C |
p. |
artikel |
4 |
Design and synthesis of selective degraders of EGFRL858R/T790M mutant
|
Zhang, Xin |
|
|
192 |
C |
p. |
artikel |
5 |
Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome
|
Sun, Qi |
|
|
192 |
C |
p. |
artikel |
6 |
Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening
|
Liu, Jian |
|
|
192 |
C |
p. |
artikel |
7 |
Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents
|
Borsoi, Ana Flávia |
|
|
192 |
C |
p. |
artikel |
8 |
Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response
|
Wu, Wei-Cheng |
|
|
192 |
C |
p. |
artikel |
9 |
Development of bivalent triarylalkene- and cyclofenil-derived dual estrogen receptor antagonists and downregulators
|
Knox, Alexandra |
|
|
192 |
C |
p. |
artikel |
10 |
Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies
|
Moreira, Joana |
|
|
192 |
C |
p. |
artikel |
11 |
Discovery of a promising agent IQZ23 for the treatment of obesity and related metabolic disorders
|
Rao, Yong |
|
|
192 |
C |
p. |
artikel |
12 |
Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate
|
Chen, Tao |
|
|
192 |
C |
p. |
artikel |
13 |
Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo
|
Fu, Dong-Jun |
|
|
192 |
C |
p. |
artikel |
14 |
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity
|
Zhang, Xuan |
|
|
192 |
C |
p. |
artikel |
15 |
Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B)
|
Zhao, Bing |
|
|
192 |
C |
p. |
artikel |
16 |
Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists
|
Xu, Xi |
|
|
192 |
C |
p. |
artikel |
17 |
Editorial Board
|
|
|
|
192 |
C |
p. |
artikel |
18 |
Fluorinated derivatives of 2-phenyl-3-hydroxy-4(1H)-quinolinone as tubulin polymerization inhibitors
|
Řehulka, Jiří |
|
|
192 |
C |
p. |
artikel |
19 |
Graphical abstract TOC
|
|
|
|
192 |
C |
p. |
artikel |
20 |
Graphical abstract TOC
|
|
|
|
192 |
C |
p. |
artikel |
21 |
Graphical abstract TOC continued
|
|
|
|
192 |
C |
p. |
artikel |
22 |
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
|
Sarkar, Rajat |
|
|
192 |
C |
p. |
artikel |
23 |
Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders
|
Xu, Pengfei |
|
|
192 |
C |
p. |
artikel |
24 |
Multi-target drug discovery: An opportunity for novel and repurposed bioactive compounds
|
Alcaro, Stefano |
|
|
192 |
C |
p. |
artikel |
25 |
Non-polyphenolic natural inhibitors of amyloid aggregation
|
Ma, Liang |
|
|
192 |
C |
p. |
artikel |
26 |
Novel androgen receptor antagonist identified by structure-based virtual screening, structural optimization, and biological evaluation
|
Tang, Qin |
|
|
192 |
C |
p. |
artikel |
27 |
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease
|
Li, Han |
|
|
192 |
C |
p. |
artikel |
28 |
Repurposed drug candidates for antituberculosis therapy
|
An, Qi |
|
|
192 |
C |
p. |
artikel |
29 |
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery
|
Yang, Ling-Ling |
|
|
192 |
C |
p. |
artikel |
30 |
Structure-thermodynamics-relationships of hepatitis C viral NS3 protease inhibitors
|
Wypych, Rachel M. |
|
|
192 |
C |
p. |
artikel |
31 |
Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease
|
Tseng, Hui-Ju |
|
|
192 |
C |
p. |
artikel |
32 |
Synthesis of antiplatelet ortho-carbonyl hydroquinones with differential action on platelet aggregation stimulated by collagen or TRAP-6
|
Méndez, Diego |
|
|
192 |
C |
p. |
artikel |
33 |
Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease
|
Martínez-Bailén, Macarena |
|
|
192 |
C |
p. |
artikel |
34 |
The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer’s disease
|
Sang, Zhipei |
|
|
192 |
C |
p. |
artikel |
35 |
True or false? Challenges and recent highlights in the development of aspirin prodrugs
|
Willetts, Steffan |
|
|
192 |
C |
p. |
artikel |